Fig 2.

Viremia development of human pegivirus during glecaprevir/pibrentasvir treatment in HCV patients with SVR. RNA titer measurements from HCV patients treated with GLE/PIB of HCV and HPgV-1 in plasma are shown at the y-axis as international units per milliliter (IU/mL) or genome equivalents per milliliter (GE/mL), respectively, and time in weeks at the x-axis. The gray boxes indicate periods during antiviral treatment with the type of treatment indicated at the top. Ribavirin addition to the treatment is indicated as RBV. Each panel represents an SVR patient. A red titer line at the y-axis represents undetectable HCV RNA titers (limit of detection 15 IU/mL). A blue titer line at the y-axis represents undetectable HPgV-1 RNA titers (limit of detection 100 GE/mL).